George C. Manuel

Array ( [id] => 4044422 [patent_doc_number] => 05874474 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-02-23 [patent_title] => 'Topical application for relief of adverse skin condition for animals' [patent_app_type] => 1 [patent_app_number] => 8/895806 [patent_app_country] => US [patent_app_date] => 1997-07-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 524 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/874/05874474.pdf [firstpage_image] =>[orig_patent_app_number] => 895806 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4009114 [patent_doc_number] => 05889026 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-03-30 [patent_title] => '4-hydroxy-piperodine derivatives' [patent_app_type] => 1 [patent_app_number] => 8/891781 [patent_app_country] => US [patent_app_date] => 1997-07-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15306 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 99 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/889/05889026.pdf [firstpage_image] =>[orig_patent_app_number] => 891781 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4085935 [patent_doc_number] => 06162820 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-12-19 [patent_title] => 'Method for removing parasites and in particular ectoparasites of vertebrates, in particular of mammals, and compositions for the implementation of this method' [patent_app_type] => 1 [patent_app_number] => 8/891047 [patent_app_country] => US [patent_app_date] => 1997-07-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3487 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/162/06162820.pdf [firstpage_image] =>[orig_patent_app_number] => 891047 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4004426 [patent_doc_number] => 06004946 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-12-21 [patent_title] => 'Treatment of global and focal ischemia using naaladase inhibitors' [patent_app_type] => 1 [patent_app_number] => 8/889358 [patent_app_country] => US [patent_app_date] => 1997-07-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 14319 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/004/06004946.pdf [firstpage_image] =>[orig_patent_app_number] => 889358 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4087251 [patent_doc_number] => 06017903 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-01-25 [patent_title] => 'Pharmaceutical compositions and methods of treating a glutamate abnormality and effecting a neuronal activity in an animal using NAALADase inhibitors' [patent_app_type] => 1 [patent_app_number] => 8/884479 [patent_app_country] => US [patent_app_date] => 1997-06-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 15 [patent_no_of_words] => 24672 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/017/06017903.pdf [firstpage_image] =>[orig_patent_app_number] => 884479 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3998185 [patent_doc_number] => 05922760 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-07-13 [patent_title] => 'Agent for prevention or alleviation of allergy symptoms' [patent_app_type] => 1 [patent_app_number] => 8/881822 [patent_app_country] => US [patent_app_date] => 1997-06-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 7692 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 121 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/922/05922760.pdf [firstpage_image] =>[orig_patent_app_number] => 881822 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4023228 [patent_doc_number] => 05925657 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-07-20 [patent_title] => 'Use of PPAR.gamma. agonists for inhibition of inflammatory cytokine production' [patent_app_type] => 1 [patent_app_number] => 8/878406 [patent_app_country] => US [patent_app_date] => 1997-06-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 12 [patent_no_of_words] => 3794 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/925/05925657.pdf [firstpage_image] =>[orig_patent_app_number] => 878406 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4036819 [patent_doc_number] => 05856361 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-01-05 [patent_title] => 'Pain reliever and method of use' [patent_app_type] => 1 [patent_app_number] => 8/870261 [patent_app_country] => US [patent_app_date] => 1997-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3065 [patent_no_of_claims] => 52 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 86 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/856/05856361.pdf [firstpage_image] =>[orig_patent_app_number] => 870261 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4010233 [patent_doc_number] => 05962459 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-10-05 [patent_title] => 'Therapeutic active agent for treatment of neuron degenerative diseases' [patent_app_type] => 1 [patent_app_number] => 8/862306 [patent_app_country] => US [patent_app_date] => 1997-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5023 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/962/05962459.pdf [firstpage_image] =>[orig_patent_app_number] => 862306 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3815631 [patent_doc_number] => 05789439 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-08-04 [patent_title] => 'Pharmaceutical use of forskolin derivatives' [patent_app_type] => 1 [patent_app_number] => 8/861262 [patent_app_country] => US [patent_app_date] => 1997-05-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4170 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 131 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/789/05789439.pdf [firstpage_image] =>[orig_patent_app_number] => 861262 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4009824 [patent_doc_number] => 05962435 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-10-05 [patent_title] => 'Method of lowering serum cholesterol levels with 2,6-di-alkyl-4-silyl-phenols' [patent_app_type] => 1 [patent_app_number] => 8/854647 [patent_app_country] => US [patent_app_date] => 1997-05-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7001 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/962/05962435.pdf [firstpage_image] =>[orig_patent_app_number] => 854647 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3874331 [patent_doc_number] => 05824665 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-10-20 [patent_title] => 'Reduction of hair growth' [patent_app_type] => 1 [patent_app_number] => 8/842054 [patent_app_country] => US [patent_app_date] => 1997-04-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 2615 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/824/05824665.pdf [firstpage_image] =>[orig_patent_app_number] => 842054 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4009564 [patent_doc_number] => 05889055 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-03-30 [patent_title] => 'L-carnitine and acetyl-L-carnitine combined for prevention and treatment of syndromes related to diseases of energy metabolism' [patent_app_type] => 1 [patent_app_number] => 8/826555 [patent_app_country] => US [patent_app_date] => 1997-04-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7568 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/889/05889055.pdf [firstpage_image] =>[orig_patent_app_number] => 826555 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3808860 [patent_doc_number] => 05854285 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-12-29 [patent_title] => 'Protein kinase inhibitor' [patent_app_type] => 1 [patent_app_number] => 8/825662 [patent_app_country] => US [patent_app_date] => 1997-04-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 6 [patent_no_of_words] => 1898 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 110 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/854/05854285.pdf [firstpage_image] =>[orig_patent_app_number] => 825662 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3950607 [patent_doc_number] => 05955502 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-09-21 [patent_title] => 'Use of fatty acid esters as bioadhesive substances' [patent_app_type] => 1 [patent_app_number] => 8/829496 [patent_app_country] => US [patent_app_date] => 1997-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 7 [patent_no_of_words] => 19637 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 113 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/955/05955502.pdf [firstpage_image] =>[orig_patent_app_number] => 829496 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3878634 [patent_doc_number] => 05776431 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-07-07 [patent_title] => 'Water-soluble aspirin composition' [patent_app_type] => 1 [patent_app_number] => 8/824429 [patent_app_country] => US [patent_app_date] => 1997-03-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1845 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/776/05776431.pdf [firstpage_image] =>[orig_patent_app_number] => 824429 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3771148 [patent_doc_number] => 05849776 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-12-15 [patent_title] => 'Medicaments based on metronidazole or on a synergic mixture of metronidazole and clindamycin' [patent_app_type] => 1 [patent_app_number] => 8/765064 [patent_app_country] => US [patent_app_date] => 1997-03-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1803 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/849/05849776.pdf [firstpage_image] =>[orig_patent_app_number] => 765064 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4026392 [patent_doc_number] => 05883137 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-03-16 [patent_title] => 'Compositions and methods for the control of smoking' [patent_app_type] => 1 [patent_app_number] => 8/809400 [patent_app_country] => US [patent_app_date] => 1997-03-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5185 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/883/05883137.pdf [firstpage_image] =>[orig_patent_app_number] => 809400 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3834035 [patent_doc_number] => 05814667 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-09-29 [patent_title] => 'Use of nitric oxide-releasing compounds as hypoxic cell radiation sensitizers' [patent_app_type] => 1 [patent_app_number] => 8/814419 [patent_app_country] => US [patent_app_date] => 1997-03-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 20 [patent_no_of_words] => 14506 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/814/05814667.pdf [firstpage_image] =>[orig_patent_app_number] => 814419 [rel_patent_id] =>[rel_patent_doc_number] =>)